Abstract:Lactate can be produced by many gut bacteria, but in adults its accumulation in the colon is often an indicator of microbiota perturbation. Using continuous culture anaerobic fermentor systems, we found that lactate concentrations remained low in communities of human colonic bacteria maintained at pH 6.5, even when dl -lactate was infused at 10 or 20 mM. In contrast, lower pH (5.5) led to periodic lactate accumulation following lactate infusion in three fecal microbial communities examined. Lactate accumulation was concomitant with greatly reduced butyrate and propionate production and major shifts in microbiota composition, with Bacteroidetes and anaerobic Firmicutes being replaced by Actinobacteria , lactobacilli, and Proteobacteria . Pure-culture experiments confirmed that Bacteroides and Firmicutes isolates were susceptible to growth inhibition by relevant concentrations of lactate and acetate, whereas the lactate-producer Bifidobacterium adolescentis was resistant. To investigate system behavior further, we used a mathematical model (microPop) based on 10 microbial functional groups. By incorporating differential growth inhibition, our model reproduced the chaotic behavior of the system, including the potential for lactate infusion both to promote and to rescue the perturbed system. The modeling revealed that system behavior is critically dependent on the proportion of the community able to convert lactate into butyrate or propionate. Communities with low numbers of lactate-utilizing bacteria are inherently less stable and more prone to lactate-induced perturbations. These findings can help us to understand the consequences of interindividual microbiota variation for dietary responses and microbiota changes associated with disease states. IMPORTANCE Lactate is formed by many species of colonic bacteria, and can accumulate to high levels in the colons of inflammatory bowel disease subjects. Conversely, in healthy colons lactate is metabolized by lactate-utilizing species to the short-chain fatty acids butyrate and propionate, which are beneficial for the host. Here, we investigated the impact of continuous lactate infusions (up to 20 mM) at two pH values (6.5 and 5.5) on human colonic microbiota responsiveness and metabolic outputs. At pH 5.5 in particular, lactate tended to accumulate in tandem with decreases in butyrate and propionate and with corresponding changes in microbial composition. Moreover, microbial communities with low numbers of lactate-utilizing bacteria were inherently less stable and therefore more prone to lactate-induced perturbations. These investigations provide clear evidence of the important role these lactate utilizers may play in health maintenance. These should therefore be considered as potential new therapeutic probiotics to combat microbiota perturbations.

Shaping human gut community assembly and butyrate production by controlling the arginine dihydrolase pathway

The Effect of Intrinsic Factors and Mechanisms in Shaping Human Gut Microbiota

Polysaccharide utilization loci in Bacteroides determine population fitness and community-level interactions

Design of synthetic human gut microbiome assembly and butyrate production

Pivotal Roles for pH, Lactate, and Lactate-Utilizing Bacteria in the Stability of a Human Colonic Microbial Ecosystem

Design of synthetic human gut microbiome assembly and function

Metabolic Engineering of Commensal Bacteria for Gut Butyrate Delivery and Dissection of Host-Microbe Interaction.

Elucidating human gut microbiota interactions that robustly inhibit diverse strains across different nutrient landscapes

Physiological activity of E. coli engineered to produce butyric acid

Genome scale metabolic modelling of human gut microbes to inform rational community design

Discovery of potential genes contributing to the biosynthesis of short-chain fatty acids and lactate in gut microbiota from systematic investigation in E. coli

Amino acid competition shapes gut carriage

Human gut microbiota interactions shape the long-term growth dynamics and evolutionary adaptations of Clostridioides difficile

Strain dropouts reveal interactions that govern the metabolic output of the gut microbiome

Metagenomic analysis and characterization of acidogenic microbiome and effect of pH on organic acid production

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

Lacticaseibacillus rhamnosus Strain GG (LGG) Regulate Gut Microbial Metabolites, an In Vitro Study Using Three Mature Human Gut Microbial Cultures in a Simulator of Human Intestinal Microbial Ecosystem (SHIME)

Systems biology elucidates the distinctive metabolic niche filled by the human gut microbe Eggerthella lenta

The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition

Gut-to-brain Neuromodulation by Synthetic Butyrate-Producing Commensal Bacteria

Exploring the resilience and stability of a defined human gut microbiota consortium: An isothermal microcalorimetric study